NEW YORK, Oct. 10 /PRNewswire/ -- Metastatic Breast Cancer Network (MBCN) today announced that October 13, 2007, has been designated the first Metastatic Breast Cancer Awareness Day by New York City Mayor Michael Bloomberg. Metastatic Breast Cancer Awareness Day will be held in conjunction with the MBCN's Metastatic Breast Cancer Conference targeted to women in New York City living with MBC. According to the New York State Cancer registry, last year, about 1,195 women died from breast cancer in New York City alone. Breast cancer deaths are largely attributed to metastatic breast cancer (MBC). Nationwide, it is estimated that there are 150,000 women living with MBC in the U.S. The Metastatic Breast Cancer Conference will be held in conjunction with NYU Cancer Institute and is supported by the Young Survival Coalition. Conference subjects will include an update on treatments, including the role of surgery and radiation in the management of MBC. "It is important to recognize this significant, yet underserved patient population and to provide the support, information and resources they need. Because of patients' fears and the possibility of MBC, many don't understand their risk of recurrence, which strikes some 30 percent of women diagnosed with breast cancer," said Deborah Axelrod, MD, Associate Professor of Surgery, New York University School of Medicine and a Conference speaker. "Organizations like MBCN and events like Metastatic Breast Cancer Awareness Day and the Metastatic Breast Cancer Conference will go a long way towards putting a public face on the woman with metastatic breast cancer, help ease the fears of all women who face the possibility of recurrence, and, most importantly, inform these patients that they have more options than ever before to manage their disease. We hope the women of New York City with MBC will come out on October 13 to learn about them." Additional speakers will be Amy Tiersten, MD, Associate Professor of Oncology at NYU; and Stella Lymberis, MD, of the Department of Radiation Oncology, at NYU Medical Center. MBCN seeks to raise awareness through the support of the community and events that focus on MBC. According to Larry Norton, MD, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center in New York City, "The MBCN has made significant strides toward demystifying metastatic breast cancer and informing people of their management options, realistic avenues of help and hope, and the new opportunities afforded by advancing science. Information leads to knowledge leads to rational action: that's the best antidote to fear." "Living with [metastatic breast] cancer as a chronic illness is living with uncertainty, but life is always uncertain," said Oni Faida Lampley, author of the play Tough Titty and New York City MBC patient. "I'm glad we have conferences like the MBCN Regional Conference here in New York. We need to come together to discuss our feelings, needs, and ways to constructively engage with the fact of cancer in our lives." About Metastatic Breast Cancer According to the American Cancer Society, MBC is defined as the spread of a malignant tumor from its original site (the breast) to other parts of the body. Patients with MBC need the support and recognition from the public and the larger breast cancer community in their fight for treatments to extend life as the search for a cure continues. According to the American Cancer Society, 178,480 women will be diagnosed with breast cancer in 2007. It is estimated that 150,000 women in the US are currently living with MBC. About Metastatic Breast Cancer Network MBCN is a national independent advocacy group of and for people with MBC. The organization intends to give those living with MBC a greater voice in the breast cancer community. In 2004, a group of women from the New York area with MBC, with guidance from Roz Kleban, MSW, Administrative Supervisor of Social Services at Memorial Sloan-Kettering Cancer Center, founded MBCN. MBCN is supported in part through charitable contributions from many sources including Abraxis BioScience and AstraZeneca. Conference Information: Date: Saturday, October 13, 2007 Location: NYU Medical Center, 401 East 30 Street, between 1st Avenue & FDR Drive Sign-in: 9:30 AM, Program 10 AM - 4 PM Those who are interested in additional information about the Conference or in attending should visit http://www.mbcnetwork.org.
SOURCE Metastatic Breast Cancer Network